A Form 4 filed on August 13, 2026 discloses that Lisa A. Friel, a Director associated with Westlake Chemical Partners LP (NYSE:WLKP), reported the acquisition of 5,044 Phantom Units on August 12, 2026.

Key Highlights

  • Reporting person: Lisa A. Friel, listed as a Director in relation to Westlake Chemical Partners LP
  • Security acquired: 5,044 Phantom Units of Westlake Chemical Partners LP, acquired on August 12, 2026
  • Price: $0 per Phantom Unit, per the filing
  • Transaction code: A (acquisition), reported in Table II as a derivative security
  • Unit equivalence: Each Phantom Unit is described as "the economic equivalent of one Common Unit of the Issuer"
  • Expiration window: The Phantom Units carry a date exercisable of 08/12/2027 and an expiration date of 09/12/2027
  • Post-transaction holdings: 0 Phantom Units beneficially owned following the reported transaction, held directly

Woelfel Director Role and Phantom Unit Award at Westlake Chemical Partners

According to the filing, the Form 4 was submitted on behalf of Lisa A. Friel, whose address is listed as 2801 Post Oak Blvd., Ste. 600, Houston, Texas 77056. The filing identifies Friel as a Director in relation to Westlake Chemical Partners LP (NYSE:WLKP). A remark in the filing notes that "Mr. Woelfel is a Director of Westlake Chemical Partners GP LLC, the general partner of Westlake Chemical Partners LP," indicating the disclosure relates to Woelfel's role, with Friel signing by power of attorney on his behalf via J Feng POA.

The derivative security reported is 5,044 Phantom Units, acquired on August 12, 2026, at a price of $0. The filing states that each Phantom Unit is "the economic equivalent of one Common Unit of the Issuer," with the underlying security identified as Common Units of Westlake Chemical Partners LP in the same quantity of 5,044. The Phantom Units are exercisable beginning August 12, 2027, and expire September 12, 2027, per the filing.

The filing reports 0 Phantom Units beneficially owned following the transaction, held on a direct basis. The transaction was filed as an individual filing by one reporting person, with the signature dated August 13, 2026.

What Was Disclosed

The Form 4 reports the acquisition of 5,044 Phantom Units in Westlake Chemical Partners LP at $0, with each unit equivalent to one Common Unit. The units are exercisable from August 12, 2027, through September 12, 2027.